ArticleAging2019

TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.

Tian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.